Today Ibi is present in over 20 countries where exports two thirds of its total production. The foreign market is fundamental for Ibi as export makes up 60% of its turnover.
IBI in EUROPE, NORTH AMERICA, CENTRAL AMERICA, ASIA and OCEANIA.
Thanks to continuous investment in the renovation of the production departments and to the use of original patented synthesis methods, Ibi remains competitive on the international scene guaranteing the high quality standard of its products.
Ibi produces the entire range of sterile penicillins with certifications of conformity in observance of the regulations of the European Pharmacopoeia.
The production of sterile penicillin is carried out under the conditions of current Good Manufacturing Procedures (cGMP) and is approved by the most demanding health authorities. Ibi’s production is certified by the US FDA (Food and Drug Administration), the Australian TGA (Therapeutic Goods Administration), and AIFA (Agenzia Italiana del Farmaco).
Every year Ibi is present at CPHI and DCAT.